Bionano Genomics (BNGO) Scheduled to Post Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 13th. Individual interested in listening to the company’s earnings conference call can do so using this link.

Bionano Genomics Price Performance

Shares of NASDAQ BNGO opened at $0.28 on Tuesday. The stock has a market cap of $23.92 million, a P/E ratio of -0.06 and a beta of 2.37. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.04. Bionano Genomics has a 12-month low of $0.26 and a 12-month high of $2.27. The business’s fifty day simple moving average is $0.38 and its 200-day simple moving average is $0.61.

Analysts Set New Price Targets

BNGO has been the topic of a number of analyst reports. Scotiabank restated a “sector perform” rating and issued a $1.00 price target (down from $6.00) on shares of Bionano Genomics in a research note on Wednesday, August 28th. BTIG Research lowered Bionano Genomics from a “buy” rating to a “neutral” rating in a report on Tuesday, September 10th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.